⌘K

Login Start Free

Home/Filings/4/0001424422-18-000007

4//SEC Filing

Morlock Stephen 4

Accession 0001424422-18-000007

CIK 0001504167other

View on SEC.gov Company Profile

Filed

Oct 21, 8:00 PM ET

Accepted

Oct 22, 6:39 PM ET

Size

8.9 KB

Accession

0001424422-18-000007

Insider Transaction Report

Form 4

Period: 2018-10-18

BioPharmX CorpBPMX

Morlock Stephen

Director

Transactions

Sale
Common stock
2018-10-22$0.18/sh−220,766$39,738→ 0 total
Sale
Common stock
2018-10-18$0.19/sh−439,099$83,429→ 434,857 total
Sale
Common stock
2018-10-19$0.18/sh−214,091$38,536→ 220,766 total
Sale
Common stock
2018-10-22$0.18/sh−251,071$45,193→ 0 total(indirect: By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03)

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

BioPharmX Corp

CIK 0001504167

Entity typeother

Related Parties

1

filerCIK 0001637670

Filing Metadata

Form type: 4
Filed: Oct 21, 8:00 PM ET
Accepted: Oct 22, 6:39 PM ET
Size: 8.9 KB

View on SEC.gov